Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Implant or insert
Patent
1997-10-28
1998-06-30
Azpuru, Carlos
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Implant or insert
424435, 623 12, A61F 202, A61F 204
Patent
active
057730202
ABSTRACT:
Erectile dysfunction, particularly impotence, priapism and Peyronie's disease is treated by the transurethral administration of a therapeutically effective agent. The agents are administered to the urethra by means of a penile insert (1) having a rapidly releasing coating (4) containing the agent on its exterior surface or by means of an inserter (27) carrying an agent containing dose of agent (31) which can be displaced into the urethra.
REFERENCES:
patent: 430928 (1890-06-01), Doty
patent: 977004 (1910-11-01), Grimm
patent: 1649022 (1927-11-01), Eisele
patent: 1897423 (1933-02-01), Ferri
patent: 2110962 (1938-03-01), Munro
patent: 2584166 (1952-02-01), Stevenson et al.
patent: 2649854 (1953-08-01), Salm
patent: 2696209 (1954-12-01), Varaney
patent: 2848998 (1958-08-01), Bryan
patent: 3373746 (1968-03-01), White et al.
patent: 3446206 (1969-05-01), De Lano
patent: 3463141 (1969-08-01), Mozlof
patent: 3648683 (1972-03-01), Brodie
patent: 3826828 (1974-07-01), Morel
patent: 3845770 (1974-11-01), Theeuwes et al.
patent: 3865108 (1975-02-01), Hartop
patent: 3993058 (1976-11-01), Hoff
patent: 3993072 (1976-11-01), Zaffaroni
patent: 4127118 (1978-11-01), Latorre
patent: 4311707 (1982-01-01), Birmbaum
patent: 4332243 (1982-06-01), Gutnick
patent: 4357934 (1982-11-01), Fahim
patent: 4365631 (1982-12-01), Kline
patent: 4415548 (1983-11-01), Reddy
patent: 4449980 (1984-05-01), Millar et al.
patent: 4455142 (1984-06-01), Martins et al.
patent: 4457299 (1984-07-01), Cornwell
patent: 4472376 (1984-09-01), Kamashita
patent: 4478822 (1984-10-01), Haslam et al.
patent: 4610868 (1986-09-01), Fountain et al.
patent: 4640912 (1987-02-01), Hausman
patent: 4746508 (1988-05-01), Casey et al.
patent: 4766889 (1988-08-01), Trick et al.
patent: 4801587 (1989-01-01), Voss et al.
patent: 4808174 (1989-02-01), Sorkin
patent: 4829991 (1989-05-01), Boeck
patent: 4857059 (1989-08-01), Rey et al.
patent: 4869241 (1989-09-01), Friedmann
patent: 4900303 (1990-02-01), Lemelson
patent: 5474535 (1995-12-01), Place et al.
patent: 5503843 (1996-04-01), Santus et al.
Althof, S.E., et al., "Why Do So Many People Drop Out From Auto-Injection Therapy for Impotence?", Journal of Sex & Marital Therapy 15(2):121-129 (1989).
Brindley, G.S., "Cavernosal Alpha-Blockade: A New Technique For Investigating And Treating Erectile Impotence", Brit. J. Psychiatry 143:332-337 (1983).
Fabbri, A., et al., "Endorphins in Male Impotence: Evidence for Naltrexone Stimulation of Erectile Activity in Patient Therapy", Psychoneuroendo 14:103-111 (1989).
Fishman, I.J., "Treating Erectile Dysfunction", Drug Therapy 19:102-111 (1989).
Ishii, N., et al., "Intracavernous Injection of Prostaglandin E1 for the Treatment of Erectile Impotency", Journal of Urology 141:323-325 (1989).
Kursh, E.D., et al., "Injection Therapy for Impotence", Urologic Clinics of North America 15(4): 625-629 (1988).
Lal, S.Y., et al., "Apomorphine: Clinical Studies on Erectile Impotence and Yawning", Prog. Neuro-Psychopharmacol. & Biol. Psychiat. 13:329-339 (1989).
Lee, L.M., et al., "Prostaglandin E1 v. Phentolamine/Papaverine for the Treatment of Erectile Impotence: A Double-Blind Comparison" Jour.of Urol. 141:549-550 (1989).
Levine, S.B., et al., "Side Effects of Self-Administration of Intracavernous Papaverine and Phentolamine for the Treatment of Impotence", Journal of Urology 141:54-57 (1989).
Morley, J.E., "Impotence", America Journal of Medicine 80:897-905 (1986).
Owen, J.A., et al., "Topical Nitroglycerin: A Potential Treatment for Impotence", Journal of Urology 141:546-548 (1989).
Rousseau, P., "Impotence in Elderly Men", Postgraduate Medicine 83:212-219 (1988).
Sarosdy, M.F., et al., "A Prospective Double-blind Trial of Intracorporeal Papaverine v. Prostaglandin E1 in the Treatment of Impotence", Journal of Urology 141:551-553 (1989).
Schramek,P., et al., "Dose-Dependent Effect and Side-Effect of Prostaglandin E1 in Erectile Dysfunction", British Journal Clinical Pharmac. 28:567-571 (1989).
Stackl, W., et al., "Intracavernous Injection of Prostaglandin E1 in Impotent Men", Journal of Urology 140:66-68 (1988).
Virag, R., et al., "Intracavernous Injection of Papaverine as a Diagnostic and Therapeutic Method in Erectile Failure", Angiology 35:79-87 (1984).
Waldhauser, M., et al., "Efficiency and Side Effects of Prostaglandin E1 in the Treatment of Erectile Disfunction", Journal of Urology 140:525-527 (1988).
Zorgniotti, A.W., et al., "Auto-Injection of the Corpus Cavernosum with a Vasoactive Drug Combination for Vasculogenic Impotence", Journal of Urology 133:39-41 (1985).
Andersson, K-E., et al., "Relaxation of Isolated Human Corpus Spongiosum Induced by Vasoactive Intestinal Polypeptide, Substance P, Carbachol and Electrical Field Stimulation", World Journal of Urology 1:203-208 (1983).
Andersson, K-E., et al., "Interactions Between Classical Neurotransmitters and Some Neuropeptides in Human Penile Erectile Tissues", Neuronal Messengers in Vascular Function pp. 505-524 (1987).
Andersson, K-E., et al., "Characterization of Immunoreactive Arginine Vasopressin (AVP) in and Effects on Isolated Human Penile Erectile Tissues", J. Urology 137:1278-1282 (1987).
Andersson, K-E, et al., "Immunoreactive Arginine Vasopressin (AVP) and Effects of AVP in the Human Vas Deferens", Journal of Urology 140:1054-1062 (1988).
Church, P., "Impotence, Part 1: Evaluation", HMS Health Letter pp. 4-6 (Sep., 1989).
Church, P., "Impotence, Part 2: Treatment", HMS Health Letter pp. 3-6 (Oct. 1989).
Foveaus, M., et al., "Calcium Channel Blockade and Contractile Responses in the Isolated Human Vas Deferens", Journal of Urology 138:654-658 (1987).
Foveaus, M., et al., "Effects of Some Calcium Channel Blockers on Isolated Human Penile Erectile Tissues", Journal of Urology 138:1267-1272 (1987).
Hedlund, H., et al., "Effects of Prazosin in Patients with Benign Prostatic Obstruction", Journal or Urology 130:275-278 (1983).
Hedlund, H., et al., "Pre-and Postjunctional Adreno-and Muscarinic Receptor Functions in the Isolated Human Corpus Spongiosum Urethrae", J. Auton. Pharmac. 4:241-249 (1984).
Hedlund, H., et al., "Effects of Some Peptides on Isolated Human Penile Erectile Tissue and Cavernous Artery", ACTA Physiol Scand. 124:413-419 (1985).
Hedlund, H., et al., "Contraction and Relaxation Induced by Some Prostanoids in Isolated Human Penile Erectile Tissue and Cavernous Artery", Journal of Urology 136:1245-1250 (1985).
Hedlund, H., et al., "Alpha-Adrenoceptors and Muscarinic Receptors in the Isolated Human Prostate", Journal of Urology 136:1291-1298 (1985).
Hedlund, H., et al., "Effect of Drugs Interacting with Adrenoreceptors and Muscarinic Receptors in the Epididymal and Prostatic Parts of the Human Isolated Vas Deferens", Journal Auton. Pharmacology 5:261-270 (1985).
Hedlund, H., et al., "Characterization of Contraction-Mediating Prostanoid Receptors in Human Penile Erectile Tissues", Journal of Urology 141:182-186 (1989).
Hedlund, H., et al., "Effects of the Tromboxane Receptor Antagonist AH-23848 on Human Isolated Corpus Cavernosum", Int. J. Impotence Res. 1:19-25 (1989).
Krane, R.J., et al., "Impotence", New England Journal of Medicine 321 (24):1648-1659 (1989).
Winslow, R., "Avoiding the Knife: Prostate Patients Get Choice of Treatments that Obviate Surgery", Wall Street Journal vol. CXXII No. 27.
Cavallini, G., "Minoxidil Versus Nitroglycerin: A Prospective Double-Blind Controlled Trial in Transcutaneous Erection Facilitation for Organic Impotence", Jour. Urology 146:50-53 (1991).
Mahler, J.C., et al., "Letter", JAMA 259(21):3126 (1988).
Milco, St. M., "Administration intra-uretrale de l'hormone masculine, chez l'homme", Bulletin et Memories De La Societe Roumaine D'Endocrinologie 5:436-437 (1939).
Malloy, T.R., et al., "Pharmacological treatment of impotence", Urologic
Klinge, E., et al., "Comparative study of some isolated mammalian smooth muscle effectors of penile erection", Acta Physiol. Scand., vol. 100:354-67 (1977).
Barbanti, G., et al., "Relaxation of isolated corpus cavernosum induced by smooth muscle relaxant drugs", Urol. Res., vol. 16(4):299-302 (1988).
Ahmad, S., "Sclerode
Berggren Randall G.
Gale Robert M.
Place Virgil A.
Azpuru Carlos
Reed Dianne E.
Vivus Inc.
LandOfFree
Treatment of erectile dysfunction does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of erectile dysfunction, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of erectile dysfunction will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1856251